Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • Gilead inks $140M API supply deal, tightening ties to Korean manufacturer
  • M&A / Deals

Gilead inks $140M API supply deal, tightening ties to Korean manufacturer

BioSpace

The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea's Yuhan.

Read full story

pharminent May 22, 2026 (Last updated: May 22, 2026)

BioSpace

The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea’s Yuhan.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: GBL joins CVC in 10.7bn takeover bid for Recordati
Next: Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival

Related Stories

  • M&A / Deals

Alzecure enters collaboration and with Lilly for Alzheimer’s project

pharminent June 9, 2026
  • M&A / Deals

GSK pays $10.6B for cancer biotech Nuvalent in industry’s second-biggest buy of the year

pharminent June 9, 2026
  • M&A / Deals

J&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for up to $1B

pharminent June 8, 2026

You May Have Missed

  • M&A / Deals

Alzecure enters collaboration and with Lilly for Alzheimer’s project

pharminent June 9, 2026
  • Clinical Data

ADA: AstraZeneca hands Structure a win with ‘relatively underwhelming’ GLP-1 pill data

pharminent June 9, 2026
  • M&A / Deals

GSK pays $10.6B for cancer biotech Nuvalent in industry’s second-biggest buy of the year

pharminent June 9, 2026
  • Regulatory

ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval

pharminent June 9, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.